dapi has been researched along with Corneal Angiogenesis in 1 studies
DAPI: RN given refers to parent cpd.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, anti-VEGF eyedrops seem to be a relatively safe option to treat corneal neovascularization." | 1.35 | Safety profile of topical VEGF neutralization at the cornea. ( Bachmann, B; Bock, F; Cursiefen, C; Dietrich, T; Kruse, FE; Onderka, J; Rummelt, C; Schlötzer-Schrehardt, U, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, F | 1 |
| Onderka, J | 1 |
| Rummelt, C | 1 |
| Dietrich, T | 1 |
| Bachmann, B | 1 |
| Kruse, FE | 1 |
| Schlötzer-Schrehardt, U | 1 |
| Cursiefen, C | 1 |
1 other study available for dapi and Corneal Angiogenesis
| Article | Year |
|---|---|
Safety profile of topical VEGF neutralization at the cornea.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoc | 2009 |